Showing results (21-30 of 876) with videos related to
Sort By:
Pageof 88
Leukemia & Lymphoma|January 1, 1994
Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experienceM E O'Brien, E Matutes, D Cunningham, et al.European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancerN C Tebbutt, A Norman, D Cunningham, et al.British Journal of Cancer|May 1, 1996
High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic indexM E O'Brien, S Milan, D Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancerP Ross, M Nicolson, D Cunningham, et al.British Journal of Cancer|June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancerA Saini, A R Norman, D Cunningham, et al.British Journal of Haematology|August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up resultsD Cunningham, R Powles, J Malpas, et al.British Journal of Cancer|June 2, 2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFK Sumpter, C Harper-Wynne, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.Pageof 88